THE TYSABRI TOUCH® PRESCRIBING PROGRAM

A commitment to patient safety

  • Because of the risk of PML, TYSABRI is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the TOUCH® Prescribing Program
  • Under the TOUCH Prescribing Program (REMS program), only prescribers, pharmacies, and infusion sites enrolled in the program are able to prescribe, distribute, or infuse TYSABRI
  • TYSABRI must be administered only to patients who are enrolled in and meet all the conditions of the TOUCH Prescribing Program
  • To enroll in the TOUCH Prescribing Program, prescribers and patients are required to understand the risks of treatment with TYSABRI, including PML and other opportunistic infections
  • Enrollment in the TOUCH Prescribing Program is required to prescribe, distribute, administer, or receive TYSABRI

TOUCH On-Line is a valuable resource for your office

REAL-TIME TOUCH DATA

are at your fingertips. Use TOUCH Analytics to customize your query. Data are sortable, exportable, and viewable in graph form

AUTOMATED REMINDERS

help prescribers and practices maintain compliance with the TOUCH Prescribing Program

SUMMARY OF BENEFITS

for each patient with a completed benefits investigation

STREAMLINED PROCESS

reduces administrative burden of the TOUCH Prescribing Program with fewer phone calls, electronically stored forms, and reduced faxes

RESOURCES FOR YOUR OFFICE

to assist in educating patients and staff

COPAY PROGRAM

from Biogen and the TYSABRI Infusion Assistance Program are available for eligible patients. To learn more about eligibility and participation, go to TOUCHProgram.com

Three options to get started

Only orders from infusion centers and certified pharmacies enrolled in and authorized by the TOUCH Prescribing Program will be processed.

1. Visit TOUCHProgram.com

TOUCH-authorized prescribers, pharmacies, and infusion sites can also:

2. Call the TOUCH Hotline at 1-800-456-2255 (Monday through Friday 8:30 AM to 8:00 PM ET)

3. Fax 1-800-840-1278

REAL EXPERIENCES WITH TYSABRI

Clinic staff describe key features of
TOUCH—a REMS program dedicated
to helping ensure the safety of RMS patients
on TYSABRI.

PML=progressive multifocal leukoencephalopathy.